The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux
Seiko Yoshino(The University of Tokyo), Takeharu Sakamoto(Kansai Medical University)
Cited by 52
Related Papers
NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells
|Scientific Reports|2016|36
Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus
|Scientific Reports|2016|18
Pharmacological inhibition of Mint3 attenuates tumour growth, metastasis, and endotoxic shock
|Communications Biology|2021|8
Hypoxia inducible factor‐1 activator munc‐18‐interacting protein 3 promotes tumour progression in urothelial carcinoma
|Clinical and Translational Discovery|2023|4